comprehensive -WSS

comprehensive

author：focus 2025-09-29 12:30:24 - browse：5527

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Attacks on the drug industry will lead to fewer breakthroughs

Wikipedia

WSS

Gilgo Beach: Police identify another victim in serial killing investigation

Nearly two

Verily hires former Apple Health leader as chief scientific officer

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

2 US Navy sailors arrested for allegedly spying for China

Akili, maker of video game for ADHD, to be acquired for 34 million

knowledge

comprehensive

leisure time

What does generative AI mean for health care? We asked experts

Influencer to be charged after chaos erupts in New York City's Union Square

Alkermes shareholders re

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Sports medicine is finally prioritizing gender equality

Addiction doctors spar with methadone clinics over legislation

Hollywood unions extend contract negotiations for actors

What will save rural psychiatry services? Higher Medicaid payments

BioMarin wins approval for gene therapy to treat hemophilia A

Startling documents reveal new facets of Sacklers' opioid empire

leisure time

Biden calls for immediate release of Niger's president amid apparent coup

TytoCare raises $49 million to build out AI

Adam's Biotech Scorecard: Do Sarepta's exon

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

OTC birth control: A brief history of over the counter pill design

For BCIs, commercial hurdles may be bigger than scientific ones

Wikipedia

hotspot

focus

focus